Stay updated on Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Sign up to get notified when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.

Latest updates to the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH’s transition to using “Super Intelligence” instead of “Artificial Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check8 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check36 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden page, replacing the usual study details with a standard error screen. The visible content now includes a 403 message and site footer, indicating restricted access to this ClinicalTrials.gov record.SummaryDifference18%

- Check57 days agoChange DetectedThe page's revision label was updated to Revision: v3.6.6, indicating a minor update to the page version.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This appears to be a metadata update rather than a change to the study details or content.SummaryDifference0.0%

Stay in the know with updates to Safety of Ascending Doses in Dravet Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Ascending Doses in Dravet Syndrome Clinical Trial page.